Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes (Phase 2 trial)
GLP-1 drugs such as semaglutide are much larger, protein-like molecules
The evolution of GLP-1 receptor peptides has been marked by significant advances in molecular engineering, resulting in compounds with improved stability, extended half-lives, and enhanced receptor binding affinity
PlexusDx's Precision Peptide Genetic Test ($298) analyzes variants like GIPR rs1800437 to identify how your genetics influence semaglutide response across 14 metabolic pathways
Gemcitabine (a nucleoside analogue of deoxycytoside) has been at the forefront of the past few decades as a cornerstone of PDAC treatment, despite its poor clinical efficacy
US$ 26.39
US$ 27.54
US$ 20.65
US$ 22.20
